Biogen, Inc. (BIIB)
193.34
-2.00
(-1.02%)
USD |
NASDAQ |
Jun 08, 15:36
Biogen EPS Diluted (Quarterly) : 2.153 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 1.612 |
| AbbVie, Inc. | 0.3861 |
| Amgen, Inc. | 3.344 |
| Regeneron Pharmaceuticals, Inc. | 6.752 |
| Ionis Pharmaceuticals, Inc. | -0.5612 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 319.50M |
| Revenue (Quarterly) | 2.403B |
| Total Expenses (Quarterly) | 2.084B |
| Enterprise Value | 31.11B |
| Gross Profit Margin (Quarterly) | 63.99% |
| Profit Margin (Quarterly) | 13.29% |
| Earnings Yield | 4.82% |
| Operating Earnings Yield | 8.05% |
| Normalized Earnings Yield | 5.871 |